Source: Annual Congress 2004 - COPD and lung cancer: genetics and pathogenesis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Lambers, R. Ziesche, V. Petkov, L. H. Block (Vienna, Austria). Ligand independent activation of the glucocorticoid receptor by long acting β₂ agonists. Eur Respir J 2004; 24: Suppl. 48, 2023

Member's Comments

No comment yet.

Related content which might interest you: PKA/cAMP-independent transactivation of glucocorticoid receptor by long acting β2 agonists Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006 Crosstalk between long acting b2-adrenergic receptor agonists and tiotropium: Crosstalk of b2-adrenergic and muscarinic receptors Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Unique receptor dissociation kinetics of the novel endothelin receptor antagonist macitentan Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Vasopressin is involved in endothelin receptor antagonist-induced fluid retention in rat. Differential effect of selective ETA and dual ETA/ETB receptor antagonists Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Effect of long-acting β2 adrenergic receptor agonists and glucocorticoids on extracellular matrix production Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001 Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids Source: Eur Respir J 2006; 27: 511-516 Year: 2006 Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004 In vitro pharmacological profile of CHF 5407, a potent, long-acting and selective muscarinic M3 receptor antagonist Source: Eur Respir J 2007; 30: Suppl. 51, 25s Year: 2007 Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 Modulation of cortical and respiratory activity by 5-HT2 receptor agonist in the rat Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 The dual endothelin receptor antagonist bosentan reduces TNFα induced GM-CSF release more effectively than the endothelin A receptor antagonist ambrisentan Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 In vivo potent and long-lasting bronchodilator activity of muscarinic M3 receptor antagonist CHF5407 Source: Eur Respir J 2007; 30: Suppl. 51, 26s Year: 2007 Acupuncture regulates macrophage polarization in COPD mice model by activating dopamine D2 receptor. Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 AZD3199: A potent and selective β2-adrenergic receptor agonist with rapid onset of action Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 The effects of formyl peptide receptor agonist on the asthma pathogenesis Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 The interaction of glucocorticoid and peroxisome proliferator-activated receptor γ agonist in asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 226s Year: 2006 Corticosteroid effects on cell signalling Source: Eur Respir J 2006; 27: 413-426 Year: 2006 Glycosaminoglycan synthesis is modulated by glucocorticoids and beta2-adrenergic agonists Source: Eur Respir J 2004; 24: Suppl. 48, 95s Year: 2004 Toll-like receptor 9 agonists prolong human eosinophil survival Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007